Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LRMR stock hub

Larimar Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LRMRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

412.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LRMR

In the news

Latest news · LRMR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-132.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-83.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LRMR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001374690
Company name	Larimar Therapeutics, Inc.
Country	United States
Country code	US
Cusip	517125100
Employees	71
Employees Change	6%
Employees Change Percent	9.23
Enterprise value	$279.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US5171251003
Last refreshed	2026-05-10
Market cap	$412.4M
Market cap category	Small-Cap
Price	$3.97
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	LRMR
Website	https://www.larimartx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-40.17%
FCF yield	-27.47%
P/B ratio	4.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-165.7M
Net Income Growth Years	0%
Profit Per Employee	$-2.3M
ROA	-62.31
Roa5y	-36.16
ROCE	-212.8
ROE	-132.6
Roe5y	-68.12
ROIC	-83.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	83.03%
Cagr3y	-5.67%
Cagr5y	-22.13%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$145.8M
Cash	$136.9M
Current Assets	$142M
Current Liabilities	$64.8M
Debt	$4.1M
Debt Equity	$0.05
Equity	$78.1M
Liabilities	$67.8M
Long Term Assets	$3.8M
Long Term Liabilities	$3M
Net Cash	$132.8M
Net Cash By Market Cap	$32.2
Net Cash Growth	-25.54%
Net Debt Equity	$-1.7
Tangible Book Value	$78.1M
Tangible Book Value Per Share	$0.94
WACC	9.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.19
Net Working Capital	$-58.5M
Quick ratio	2.12
Working Capital	$77.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	82.95%
200-day SMA	4.02
3Y total return	-16.07%
50-day SMA	4.71
50-day SMA vs 200-day SMA	50over200
5Y total return	-71.36%
All Time High	25.87
All Time High Change	-84.65%
All Time High Date	2020-12-08
All Time Low	1.53
All Time Low Change	159.48%
All Time Low Date	2022-08-05
ATR	0.28
Beta	0.91
Beta1y	0.85
Beta2y	1.68
Ch YTD	4.2
High	4.2
High52	6.42
High52 Date	2026-02-25
High52ch	-38.16%
Low	3.95
Low52	1.73
Low52 Date	2025-05-15
Low52ch	129.48%
Ma50ch	-15.69%
Premarket Change Percent	0.75
Premarket Price	$4.03
Premarket Volume	4,496
Price vs 200-day SMA	-1.15%
RSI	37.35
RSI Monthly	47.68
RSI Weekly	48.61
Sharpe ratio	1.02x
Sortino ratio	1.99
Tr YTD	4.2
Tr1m	-21.23%
Tr1w	0.76%
Tr3m	17.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	5
Analyst Price Target Top	$17
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.56
Operating Income	$-172.5M
Price target	$16.5
Price Target Change	$316
Price Target Change Top	$353

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60,286,240%
Float Percent	58.03%
Shares Insiders	1.12%
Shares Institutions	33.49%
Shares Out	103,882,937
Shares Qo Q	8.76%
Shares Yo Y	19.09%
Short Float	12.16%
Short Ratio	4.18
Short Shares	7.06

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-120.3M
Average Volume	1,459,435.15x
Bv Per Share	0.94
CAPEX	$-91,000
Ch1m	-21.23
Ch1w	0.76
Ch1y	82.95
Ch3m	17.8
Ch3y	-16.07
Ch5y	-71.36
Ch6m	14.74
Change	-0.75%
Change From Open	-1.24
Close	4
Days Gap	0.5
Depreciation Amortization	350,000
Dollar Volume	5,926,026.9
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-172.5M
EBITDA	$-172.1M
EPS	$-2.27
F Score	1
FCF	$-113.3M
FCF EV Yield	-40.51x
FCF Per Share	$-1.09
Financing CF	65,086,000
Fiscal Year End	December
Investing CF	100,309,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-19
Ma150	4.05
Ma150ch	-1.98%
Ma20	4.43
Ma20ch	-10.36%
Net CF	52,194,000
Next Earnings Date	2026-05-22
Open	4.02
Optionable	Yes
Position In Range	9.8
Post Close	3.97
Postmarket Change Percent	6.55
Postmarket Price	$4.23
Ppne	2,691,000
Pre Close	4
Price Date	2026-05-08
Ptbv Ratio	5.28
Relative Volume	1.02x
Share Based Comp	7,004,000
Tr6m	14.74%
Us State	Pennsylvania
Volume	1,492,702

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LRMR pay a dividend?

Capital-return profile for this ticker.

Performance

LRMR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LRMR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.5%

Float: +58.0% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LRMR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.4

Neutral momentum band

Price vs 200-day MA

-1.1%

50/200-day relationship not available

Beta (5Y)

0.91

Moves roughly with the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LRMR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LRMR stock rating?

Larimar Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LRMR analysis?

The full report lives at /stocks/LRMR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LRMR?

The latest report frames LRMR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LRMR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.